Form 4 for MRNA Moderna
Accepted 2024-07-09 00:00:00 ET · period of report 2024-07-05 · accession 0001127602-24-020247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-09 | 2024-07-08 | MRNA | Mock James M | CFO | S - Sale+OE | $118.24 | -689 | 7,269 | -9% | -$81.5K |
| D | 2024-07-09 | 2024-07-05 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 7,958 | +22% | — |
| D | 2024-07-09 | 2024-07-05 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -1,452 | 13.1K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-08 | S | D | 689 | $118.24 | 7,269 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-05 | M | A | 1,452 | — | 7,958 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2024-07-05 | M | D | 1,452 | $0.00 | 13,075 | D | — · — to — | 1,452 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |